REVOLUTION IN HEPATITIS C TREATMENT

  • News
  • April 21, 2016

A new strong ray of hope has come in controlling the epidemic of chronic hepatits C in various part of India which includes haryana & Punjab. Further elaborating about it, Dr. Parveen Malhotra, Head, Departmentof Medical Gastroenterology and Principal Nodal officer of Jeevan Rekha project of Haryana Government told it is the availability of combination of oral drugs i.e. Sofosbuvir with Ledipasvir/Daclatasvir at much economical prices. These drugs are being given free by to SC/BPL patients and at subsidized prices to general category patients i.e. Rs 8800/month and total Rs 26,000 for total duration of 12 weeks which is lowest not only in India but in world also. Even all the viral load and genotype testing, Endoscopy and Fibroscan are also being done free of cost. Patients suffering from hepatitis B also are being treated at a meagre price of Rs 500/month. As this disease is mainly seen in patients belonging to poor socio-economic status, thus many patients will be able to afford it who are not covered under free scheme of govt. This project is unique and has been appreciated by various international organizations like MSF and Clinton foundation. Uptill now the treatment was with Pegylated Interferon & ribavarin which has lot of side effects and cost was also more.There are many patients who never took treatment or left in between due to side effects of Pegylated Interferon. Moreover, these Pegylated interferon cannot be given or are not much successful when there is advanced liver damage but these new oral drugs are successful in all these group of patients. The Jeevan Rekha scheme of Haryana government against hepatitis C is giving new life to thousands of patients suffering from this deadly disease.Uptillnow 5000 patients have successfully completed the treatment, which makes PGIMS, Rohtak, one of the selected centers in India where such huge number of patients are being treated at on time and that too with massive success. The patients are also coming for treatment from nearby states like Punjab, Delhi, Uttarakhand and Chandigarh Moreover, round the clock, India’s first dedicated hepatitis C helpline has also been opened for needy patients (08950012900).

Related Posts

MedTech Zone AMTZ Puts Vizag on the Science Map of India

Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

  • News
  • May 27, 2025
  • 255 views
Ramping Up Community for JeevanRaksha during Disasters

CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cipla in talks to add new customers for its China factory, executive says

Cipla in talks to add new customers for its China factory, executive says

No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs